Search

Your search keyword '"Sasada, Tetsuro"' showing total 637 results
Start Over Author "Sasada, Tetsuro"
637 results on '"Sasada, Tetsuro"'

13. List of contributors

Author

Adamik, Juraj, primary, Aurisicchio, Luigi, additional, Bell, John C., additional, Bourgeois-Daigneault, Marie-Claude, additional, Butterfield, Lisa H., additional, Cerullo, Vincenzo, additional, Chiang, Cheryl L.-L., additional, Ciliberto, Gennaro, additional, Conforti, Antonella, additional, Finn, Olivera J., additional, Galli, Maria Cristina, additional, Hadrup, Sine Reker, additional, Hamilton, Duane H., additional, Hawthorne, Jenci, additional, Himuro, Hidetomo, additional, Jacqueline, Camille, additional, Jochems, Caroline, additional, Kadivar, Mohammad, additional, Kandalaft, Lana E., additional, Melief, Cornelis J.M., additional, Munson, Paul V., additional, Nappi, Filomena, additional, Palombo, Fabio, additional, Rammensee, Hans-Georg, additional, Sasada, Tetsuro, additional, Schlom, Jeffrey, additional, Shirwan, Haval, additional, Tagliamonte, Maria, additional, van der Gracht, Esmé T.I., additional, Wiekmeijer, Anna-Sophia, additional, Ylösmäki, Erkko, additional, and Yolcu, Esma, additional

Published
2022
Full Text
View/download PDF

15. Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors

Author

Nakahara, Yoshiro, primary, Kouro, Taku, additional, Motoyama, Satoru, additional, Miura, Masatomo, additional, Fujita, Kazuma, additional, Igarashi, Yuka, additional, Higashijima, Naoko, additional, Matsuo, Norikazu, additional, Himuro, Hidetomo, additional, Wei, Feifei, additional, Horaguchi, Shun, additional, Tsuji, Kayoko, additional, Mano, Yasunobu, additional, Komahashi, Mitsuru, additional, Saito, Haruhiro, additional, Azuma, Koichi, additional, and Sasada, Tetsuro, additional

Published
2024
Full Text
View/download PDF

16. Novel chimeric antigen receptor‐expressing T cells targeting the malignant mesothelioma‐specific antigen sialylated HEG1.

Author

Kouro, Taku, Higashijima, Naoko, Horaguchi, Shun, Mano, Yasunobu, Kasajima, Rika, Xiang, Huihui, Fujimoto, Yuki, Kishi, Hiroyuki, Hamana, Hiroshi, Hoshino, Daisuke, Himuro, Hidetomo, Matsuura, Rieko, Tsuji, Shoutaro, Imai, Kohzoh, and Sasada, Tetsuro

Subjects
T cells, T cell receptors, CANCER cells, CHIMERIC antigen receptors, ANTIGENS, GENE expression profiling, CHIMERIC proteins
Abstract

The selection of highly specific target antigens is critical for the development of clinically efficient and safe chimeric antigen receptors (CARs). In search of diagnostic marker for malignant mesothelioma (MM), we have established SKM9‐2 monoclonal antibody (mAb) which recognizes a MM‐specific molecule, sialylated Protein HEG homolog 1 (HEG1), with high specificity and sensitivity. In this study, to develop a novel therapeutic approach against MM, we generated SKM9‐2 mAb‐derived CARs that included the CD28 (SKM‐28z) or 4‐1BB (SKM‐BBz) costimulatory domain. SKM‐28z CAR‐T cells showed continuous growth and enhanced Tim‐3, LAG‐3, and PD‐1 expression in vitro, which might be induced by tonic signaling caused by self‐activation; however, these phenotypes were not observed in SKM‐BBz CAR‐T cells. In addition, SKM‐BBz CAR‐T cells exhibited slightly stronger in vitro killing activity against MM cell lines than SKM‐28z CAR‐T cells. More importantly, only SKM‐BBz CAR‐T cells, but not SKM‐28z CAR‐T cells, significantly inhibited tumor growth in vivo in a MM cell line xenograft mouse model. Gene expression profiling and reporter assays revealed differential signaling pathway activation; in particular, SKM‐BBz CAR‐T cells exhibited enhanced NF‐kB signaling and reduced NFAT activation. In addition, SKM‐BBz CAR‐T cells showed upregulation of early memory markers, such as TCF7 and CCR7, as well as downregulation of pro‐apoptotic proteins, such as BAK1 and BID, which may be associated with phenotypical and functional differences between SKM‐BBz and SKM‐28z CAR‐T cells. In conclusion, we developed novel SKM9‐2‐derived CAR‐T cells with the 4‐1BB costimulatory domain, which could provide a promising therapeutic approach against refractory MM. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

18. O16-2 Phase I trial of NY-ESO-1 TCR-T cell therapy combined with nanoparticulate vaccine but without lymphodepletion for STS

Author

Ishihara, Mikiya, primary, Nishida, Yoshihiro, additional, Kitano, Shigehisa, additional, Kawai, Akira, additional, Harada, Naozumi, additional, Miyahara, Yoshihiro, additional, Hattori, Hiroyoshi, additional, Takada, Kohichi, additional, Emori, Makoto, additional, Kakunaga, Shigeki, additional, Endo, Makoto, additional, Matsumoto, Yoshihiro, additional, Sasada, Tetsuro, additional, Sato, Eiichi, additional, Yamada, Tomomi, additional, Matsumine, Akihiko, additional, Nagata, Yasuhiro, additional, Kageyama, Shinichi, additional, and Shiku, Hiroshi, additional

Published
2023
Full Text
View/download PDF

25. Data from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

26. Data from Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer

Author

Kibe, Shiro, primary, Yutani, Shigeru, primary, Motoyama, Satoru, primary, Nomura, Takanobu, primary, Tanaka, Natsuki, primary, Kawahara, Akihiko, primary, Yamaguchi, Tomohiko, primary, Matsueda, Satoko, primary, Komatsu, Nobukazu, primary, Miura, Masatomo, primary, Hinai, Yudai, primary, Hattori, Satoshi, primary, Yamada, Akira, primary, Kage, Masayoshi, primary, Itoh, Kyogo, primary, Akagi, Yoshito, primary, and Sasada, Tetsuro, primary

Published
2023
Full Text
View/download PDF

27. Supplementary Methods from Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer

Author

Kibe, Shiro, primary, Yutani, Shigeru, primary, Motoyama, Satoru, primary, Nomura, Takanobu, primary, Tanaka, Natsuki, primary, Kawahara, Akihiko, primary, Yamaguchi, Tomohiko, primary, Matsueda, Satoko, primary, Komatsu, Nobukazu, primary, Miura, Masatomo, primary, Hinai, Yudai, primary, Hattori, Satoshi, primary, Yamada, Akira, primary, Kage, Masayoshi, primary, Itoh, Kyogo, primary, Akagi, Yoshito, primary, and Sasada, Tetsuro, primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figure 7 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure Legends from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

30. Supplementary Figure 1 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

31. Supplementary Table S5 from Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer

Author

Kibe, Shiro, primary, Yutani, Shigeru, primary, Motoyama, Satoru, primary, Nomura, Takanobu, primary, Tanaka, Natsuki, primary, Kawahara, Akihiko, primary, Yamaguchi, Tomohiko, primary, Matsueda, Satoko, primary, Komatsu, Nobukazu, primary, Miura, Masatomo, primary, Hinai, Yudai, primary, Hattori, Satoshi, primary, Yamada, Akira, primary, Kage, Masayoshi, primary, Itoh, Kyogo, primary, Akagi, Yoshito, primary, and Sasada, Tetsuro, primary

Published
2023
Full Text
View/download PDF

32. Supplementary Figure 2 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Table 4 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Table 2 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

35. Supplementary Figure 4 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure S2 from Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer

Author

Kibe, Shiro, primary, Yutani, Shigeru, primary, Motoyama, Satoru, primary, Nomura, Takanobu, primary, Tanaka, Natsuki, primary, Kawahara, Akihiko, primary, Yamaguchi, Tomohiko, primary, Matsueda, Satoko, primary, Komatsu, Nobukazu, primary, Miura, Masatomo, primary, Hinai, Yudai, primary, Hattori, Satoshi, primary, Yamada, Akira, primary, Kage, Masayoshi, primary, Itoh, Kyogo, primary, Akagi, Yoshito, primary, and Sasada, Tetsuro, primary

Published
2023
Full Text
View/download PDF

37. Supplementary Methods from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

38. Supplementary Table 1 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure 6 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

40. Supplementary Table 3 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figure 5 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

42. Supplementary Figure 3 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

Author

Hodi, F. Stephen, primary, Lawrence, Donald, primary, Lezcano, Cecilia, primary, Wu, Xinqi, primary, Zhou, Jun, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Giobbie-Hurder, Anita, primary, Atkins, Michael B., primary, Ibrahim, Nageatte, primary, Friedlander, Philip, primary, Flaherty, Keith T., primary, Murphy, George F., primary, Rodig, Scott, primary, Velazquez, Elsa F., primary, Mihm, Martin C., primary, Russell, Sara, primary, DiPiro, Pamela J., primary, Yap, Jeffrey T., primary, Ramaiya, Nikhil, primary, Van den Abbeele, Annick D., primary, Gargano, Maria, primary, and McDermott, David, primary

Published
2023
Full Text
View/download PDF

43. Named Entity Recognizer Trainable from Partially Annotated Data

Author

Sasada, Tetsuro, Mori, Shinsuke, Kawahara, Tatsuya, Yamakata, Yoko, Diniz Junqueira Barbosa, Simone, Series editor, Chen, Phoebe, Series editor, Du, Xiaoyong, Series editor, Filipe, Joaquim, Series editor, Kara, Orhun, Series editor, Liu, Ting, Series editor, Kotenko, Igor, Series editor, Sivalingam, Krishna M., Series editor, Washio, Takashi, Series editor, Hasida, Kôiti, editor, and Purwarianti, Ayu, editor

Published
2016
Full Text
View/download PDF

44. Pointwise Prediction and Sequence-Based Reranking for Adaptable Part-of-Speech Tagging

Author

Mori, Shinsuke, Nakata, Yosuke, Neubig, Graham, Sasada, Tetsuro, Diniz Junqueira Barbosa, Simone, Series editor, Chen, Phoebe, Series editor, Du, Xiaoyong, Series editor, Filipe, Joaquim, Series editor, Kara, Orhun, Series editor, Liu, Ting, Series editor, Kotenko, Igor, Series editor, Sivalingam, Krishna M., Series editor, Washio, Takashi, Series editor, Hasida, Kôiti, editor, and Purwarianti, Ayu, editor

Published
2016
Full Text
View/download PDF

46. supplemental legend from Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma

Author

Curry, William T., primary, Gorrepati, Ramana, primary, Piesche, Matthias, primary, Sasada, Tetsuro, primary, Agarwalla, Pankaj, primary, Jones, Pamela S., primary, Gerstner, Elizabeth R., primary, Golby, Alexandra J., primary, Batchelor, Tracy T., primary, Wen, Patrick Y., primary, Mihm, Martin C., primary, and Dranoff, Glenn, primary

Published
2023
Full Text
View/download PDF

47. Supplemental Figures from Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

Author

Exley, Mark A., primary, Friedlander, Phillip, primary, Alatrakchi, Nadia, primary, Vriend, Lianne, primary, Yue, Simon, primary, Sasada, Tetsuro, primary, Zeng, Wanyong, primary, Mizukami, Yo, primary, Clark, Justice, primary, Nemer, David, primary, LeClair, Kenneth, primary, Canning, Christine, primary, Daley, Heather, primary, Dranoff, Glenn, primary, Giobbie-Hurder, Anita, primary, Hodi, F. Stephen, primary, Ritz, Jerome, primary, and Balk, Steven P., primary

Published
2023
Full Text
View/download PDF

48. Change in T lymphocyte from Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma

Author

Curry, William T., primary, Gorrepati, Ramana, primary, Piesche, Matthias, primary, Sasada, Tetsuro, primary, Agarwalla, Pankaj, primary, Jones, Pamela S., primary, Gerstner, Elizabeth R., primary, Golby, Alexandra J., primary, Batchelor, Tracy T., primary, Wen, Patrick Y., primary, Mihm, Martin C., primary, and Dranoff, Glenn, primary

Published
2023
Full Text
View/download PDF

49. Sapplemental Table 1 from An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy

Author

Noguchi, Masanori, primary, Matsumoto, Kazumasa, primary, Uemura, Hirotsugu, primary, Arai, Gaku, primary, Eto, Masatoshi, primary, Naito, Seiji, primary, Ohyama, Chikara, primary, Nasu, Yasutomo, primary, Tanaka, Masatoshi, primary, Moriya, Fukuko, primary, Suekane, Shigetaka, primary, Matsueda, Satoko, primary, Komatsu, Nobukazu, primary, Sasada, Tetsuro, primary, Yamada, Akira, primary, Kakuma, Tatsuyuki, primary, and Itoh, Kyogo, primary

Published
2023
Full Text
View/download PDF

50. Data from Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion

Author

Zhang, Wandi, primary, Choi, Jaewon, primary, Zeng, Wanyong, primary, Rogers, Shelby A., primary, Alyea, Edwin P., primary, Rheinwald, James G., primary, Canning, Christine M., primary, Brusic, Vladimir, primary, Sasada, Tetsuro, primary, Reinherz, Ellis L., primary, Ritz, Jerome, primary, Soiffer, Robert J., primary, and Wu, Catherine J., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results